Detailed Report on Blood Glucose Meters - Medical Devices Pipeline Assessment, 2017

Blood Glucose Meters - Medical Devices Pipeline Assessment, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Blood Glucose Meters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Blood Glucose Meters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Complete report available @ Blood Glucose Meters - Medical Devices Pipeline Assessment, 2017

Scope

- Extensive coverage of the Blood Glucose Meters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Blood Glucose Meters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Blood Glucose Meters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

4a Medicom GmbH A. Menarini Diagnostics S.r.l. Abbott Diabetes Care, Inc. Advanced Biosensors-Ohio, Llc Advanced Medical Electronics Corporation AirMarkers Animas Corp Arkal Medical, Inc. Arkray Inc Ascensia Diabetes Care Holdings AG Azurite Technologies, Inc. Bar-Ilan University Baylor University Bio-Impedance General Ltd. Biopeak Corp Biorasis, Inc. BioTelemetry Inc BioTex Inc Biovotion AG BlueVine Graphene Industries, Inc. Brigham and Women's Hospital CALISTO MEDICAL, INC. Cardiff University Cell MedX Corp CGM3 Ltd City, University of London Columbia University ConvaTec Group Plc Cyber Medical Ltd. DarioHealth Corp Debiotech SA DexCom Inc DiaMonTech GmbH DIRAmed LLC. DirectSens GmbH Echo Therapeutics Inc Ecole Polytechnique Federale de Lausanne eLutions Integrated Systems, Inc. Emperra GmbH E-Health Technologies EyeSense GmbH Flowsion A/S Gili Medical Ltd Globe Medical Tech Inc GlucoLight Corporation GlucoMe Ltd Glucometrix AG Glucosat Glucosense Diagnostics Ltd GlucoSet AS GlucoStats System Pte Ltd. Glucovation Inc GluMetrics Inc GlySens Inc GlySure Ltd Grove Instruments Inc. G-Sense Ltd. Guided Therapeutics Inc i360medical Limited iGlyko, Inc. Indigo Diabetes NV InLight Solutions Inc. Institute of Biomedical Engineering (ISIB-CNR) Insulet Corp Integrated Medical Group of Irvine Integrity Applications Ltd IntelliDx Inc Intuity Medical Inc Invivomon Inc Invivosense ASA iSense Corporation iXensor Co. Ltd. KeenCAT Technologies Lein Applied Diagnostics Limited LEMM Technologies, LLC LifeScan Inc LighTouch Medical, Inc. Luminous Medical Inc Lyte Labs M Pharmaceutical Inc Massachusetts Institute of Technology MASTInc Medella Health Inc. Medical Wireless Sensing Ltd Medtronic plc Mellitor Ltd. Microchips Biotech Inc MIT Spectroscopy Lab mobiLIFE Nagasaki University Nemaura Medical Inc Newton Photonics Inc NIR Diagnostics Inc. Northwestern University NovioSense BV Optiscan Biomedical Corp Pelikan Technologies, Inc. Pepex Biomedical, Inc. Pignolo SpA Pop Test LLC POPS! Diabetes Care Inc PositiveID Corp Prediktor AS Profusa, Inc. Purdue University Q Step Technologies, Inc. Roche Diabetes Care Inc Royal Adelaide Hospital SA RSP Systems A/S San Meditech (Huzhou) Co., Ltd. Senseonics, Incorporated SensiVida Medical Technologies, Inc. Sensys Medical, Inc. Sentec Pte Ltd Sentek Group, Inc. Senzime AB Shield Diagnostics Singapore Biomicro Pte Ltd Socrates Health Solutions, Inc. Spire Corporation St. Louis Medical Devices, Inc TecMed, Inc. Tenax Therapeutics Inc Terumo Corp Texas A&M University Ultradian Diagnostics LLC University of Bath University of California Berkeley University of California Irvine University of California San Diego University of Central Florida University of Oxford University of South Florida University of Texas at Arlington Vytrace, Inc. Zyvex Corporation

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###